Corrigendum to “Disruption of KATP Channel Expression in Skeletal Muscle by Targeted Oligonucleotide Delivery Promotes Activity-linked Thermogenesis” (Molecular Therapy (2015) 23(4) (707–716)(S1525001616300909)(10.1038/mt.2015.21));Disruption of KATP channel expression in skeletal muscle by targeted oligonucleotide delivery promotes activity-linked thermogenesis

Molecular Therapy

Volumn 23, Issue 4, 2015, Pages 707-716

  Koganti, Siva Rama Krishna ^a   Zhu, Zhiyong ^a   Subbotina, Ekaterina ^a   Gao, Zhan ^a   Sierra, Ana ^a   Proenza, Manuel ^a   Yang, Liping ^b   Alekseev, Alexey ^c   Hodgson Zingman, Denice ^a   Zingman, Leonid ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANTIOBESITY AGENT; ANTISENSE OLIGONUCLEOTIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; UNCLASSIFIED DRUG; VIVO MORPHOLINO; MORPHOLINO OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY TRANSFER; EXERCISE TOLERANCE; GASTROCNEMIUS MUSCLE; HEART; MALE; METABOLIC RATE; MOUSE; MUSCLE FIBER MEMBRANE POTENTIAL; MUSCLE METABOLISM; NONHUMAN; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SKELETAL MUSCLE; THERMOGENESIS; TIBIALIS ANTERIOR MUSCLE; ANIMAL; C57BL MOUSE; GENETICS; METABOLISM;

ANIMALS; KATP CHANNELS; MALE; MICE; MICE, INBRED C57BL; MORPHOLINOS; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; THERMOGENESIS;

EID: 84926989797     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2015.186     Document Type: Erratum

References (49)

1. Blair, SN and Nichaman, MZ (2002). The public health problem of increasing prevalence rates of obesity and what should be done about it. Mayo Clin Proc 77: 109-113.
2. Flegal, KM, Carroll, MD, Kit, BK and Ogden, CL (2012). Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497.
3. Yanovski, SZ and Yanovski, JA (2002). Obesity. N Engl J Med 346: 591-602.
4. Tseng, YH, Cypess, AM and Kahn, CR (2010). Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov 9: 465-482.
5. Wadden, TA, Berkowitz, RI, Womble, LG, Sarwer, DB, Phelan, S, Cato, RK et al. (2005). Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 353: 2111-2120.
6. Barsh, GS and Schwartz, MW (2002). Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 3: 589-600.
7. Schwartz, MW, Woods, SC, Seeley, RJ, Barsh, GS, Baskin, DG and Leibel, RL (2003). Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52: 232-238.
8. Spriet, LL and Hargreaves, M. Overview of exercise metabolism. In: Hargreaves M, Spriet LL (eds.) Exercise Metabolism, Human Kinetics, Champaign, IL, 2006.
9. Alekseev, AE, Reyes, S, Yamada, S, Hodgson-Zingman, DM, Sattiraju, S, Zhu, Z et al. (2010). Sarcolemmal ATP-sensitive K(+) channels control energy expenditure determining body weight. Cell Metab 11: 58-69.
10. Zhu, Z, Burnett, CM, Maksymov, G, Stepniak, E, Sierra, A, Subbotina, E et al. (2011). Reduction in number of sarcolemmal KATP channels slows cardiac action potential duration shortening under hypoxia. Biochem Biophys Res Commun 415: 637-641.
11. Zhu, Z, Sierra, A, Burnett, CM, Chen, B, Subbotina, E, Koganti, SR et al. (2014). Sarcolemmal ATP-sensitive potassium channels modulate skeletal muscle function under low-intensity workloads. J Gen Physiol 143: 119-134.
12. Zingman, LV, Zhu, Z, Sierra, A, Stepniak, E, Burnett, CM, Maksymov, G et al. (2011). Exercise-induced expression of cardiac ATP-sensitive potassium channels promotes action potential shortening and energy conservation. J Mol Cell Cardiol 51: 72-81.
13. Flagg, TP, Enkvetchakul, D, Koster, JC and Nichols, CG (2010). Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev 90: 799-829.
14. Nichols, CG and Lederer, WJ (1991). Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 261(6 Pt 2): H1675-H1686.
15. Gong, B, Miki, T, Seino, S and Renaud, JM (2000). A K(ATP) channel deficiency affects resting tension, not contractile force, during fatigue in skeletal muscle. Am J Physiol Cell Physiol 279: C1351-C1358.
16. Zingman, LV, Hodgson, DM, Bast, PH, Kane, GC, Perez-Terzic, C, Gumina, RJ et al. (2002). Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci USA 99: 13278-13283.
17. Thabet, M, Miki, T, Seino, S and Renaud, JM (2005). Treadmill running causes significant fiber damage in skeletal muscle of KATP channel-deficient mice. Physiol Genomics 22: 204-212.
18. MacIntosh, BR, Holash, RJ and Renaud, JM (2012). Skeletal muscle fatigue-regulation of excitation-contraction coupling to avoid metabolic catastrophe. J Cell Sci 125(Pt 9): 2105-2114.
19. Cifelli, C, Bourassa, F, Gariépy, L, Banas, K, Benkhalti, M and Renaud, JM (2007). KATP channel deficiency in mouse flexor digitorum brevis causes fibre damage and impairs Ca2+ release and force development during fatigue in vitro. J Physiol 582(Pt 2): 843-857.
20. Cifelli, C, Boudreault, L, Gong, B, Bercier, JP and Renaud, JM (2008). Contractile dysfunctions in ATP-dependent K+ channel-deficient mouse muscle during fatigue involve excessive depolarization and Ca2+ influx through L-type Ca2+ channels. Exp Physiol 93: 1126-1138.
21. Gribble, FM and Reimann, F (2003). Sulphonylurea action revisited: the post-cloning era. Diabetologia 46: 875-891.
22. Selvin, E, Bolen, S, Yeh, HC, Wiley, C, Wilson, LM, Marinopoulos, SS et al. (2008). Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med 168: 2070-2080.
23. Aguilar-Bryan, L and Bryan, J. (1999) Molecular biology of adenosine triphosphatesensitive potassium channels. Endocrine Rev 20: 101.
24. Clement, JP 4th, Kunjilwar, K, Gonzalez, G, Schwanstecher, M, Panten, U, Aguilar- Bryan, L et al. (1997). Association and stoichiometry of K(ATP) channel subunits. Neuron 18: 827-838.
25. Barclay, CJ, Woledge, RC and Curtin, NA (2010). Is the efficiency of mammalian (mouse) skeletal muscle temperature dependent? J Physiol 588(Pt 19): 3819-3831.
26. Wu, B, Li, Y, Morcos, PA, Doran, TJ, Lu, P and Lu, QL (2009). Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice. Mol Ther 17: 864-871.
27. Morcos, PA, Li, Y and Jiang, S (2008). Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues. Biotechniques 45: 613-4, 616, 618 passim.
28. Hodgson, DM, Zingman, LV, Kane, GC, Perez-Terzic, C, Bienengraeber, M, Ozcan, C et al. (2003). Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance. EMBO J 22: 1732-1742.
29. Seino, S and Miki, T (2003). Physiological and pathophysiological roles of ATPsensitive K+ channels. Prog Biophys Mol Biol 81: 133-176.
30. Kane, GC, Behfar, A, Dyer, RB, O'Cochlain, DF, Liu, XK, Hodgson, DM et al. (2006). KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet 15: 2285-2297.
31. Davis-Taber, R, Choi, W, Feng, J, Hoogenboom, L, McNally, T, Kroeger, P et al. (2000). Molecular characterization of human SUR2-containing K(ATP) channels. Gene 256: 261-270.
32. Yamada, M, Isomoto, S, Matsumoto, S, Kondo, C, Shindo, T, Horio, Y et al. (1997). Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATPinsensitive K+ channel. J Physiol 499 (Pt 3): 715-720.
33. Chutkow, WA, Pu, J, Wheeler, MT, Wada, T, Makielski, JC, Burant, CF et al. (2002). Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin Invest 110: 203-208.
34. Miki, T, Suzuki, M, Shibasaki, T, Uemura, H, Sato, T, Yamaguchi, K et al. (2002). Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8: 466-472.
35. Jearawiriyapaisarn, N, Moulton, HM, Sazani, P, Kole, R and Willis, MS (2010). Longterm improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers. Cardiovasc Res 85: 444-453.
36. Goyenvalle, A, Babbs, A, Powell, D, Kole, R, Fletcher, S, Wilton, SD et al. (2010). Prevention of dystrophic pathology in severely affected dystrophin/utrophindeficient mice by morpholino-oligomer-mediated exon-skipping. Mol Ther 18: 198-205.
37. Crisp, A, Yin, H, Goyenvalle, A, Betts, C, Moulton, HM, Seow, Y et al. (2011). Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum Mol Genet 20: 413-421.
38. Widrick, JJ, Jiang, S, Choi, SJ, Knuth, ST and Morcos, PA (2011). An octaguanidinemorpholino oligo conjugate improves muscle function of mdx mice. Muscle Nerve 44: 563-570.
39. Wu, B, Xiao, B, Cloer, C, Shaban, M, Sali, A, Lu, P et al. (2011). One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice. Mol Ther 19: 576-583.
40. Taniguchi-Ikeda, M, Kobayashi, K, Kanagawa, M, Yu, CC, Mori, K, Oda, T et al. (2011). Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478: 127-131.
41. Moulton, JD and Jiang, S (2009). Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules 14: 1304-1323.
42. Light, PE, Comtois, AS and Renaud, JM (1994). The effect of glibenclamide on frog skeletal muscle: evidence for K+ATP channel activation during fatigue. J Physiol 475: 495-507.
43. Matar, W, Nosek, TM, Wong, D and Renaud, J (2000). Pinacidil suppresses contractility and preserves energy but glibenclamide has no effect during muscle fatigue. Am J Physiol Cell Physiol 278: C404-C416.
44. Matar, W, Lunde, JA, Jasmin, BJ and Renaud, JM (2001). Denervation enhances the physiological effects of the K(ATP) channel during fatigue in EDL and soleus muscle. Am J Physiol Regul Integr Comp Physiol 281: R56-R65.
45. Renaud, JM (2002). Modulation of force development by Na+, K+, Na+ K+ pump and KATP channel during muscular activity. Can J Appl Physiol 27: 296-315.
46. Gong, B, Legault, D, Miki, T, Seino, S and Renaud, JM (2003). KATP channels depress force by reducing action potential amplitude in mouse EDL and soleus muscle. Am J Physiol Cell Physiol 285: C1464-C1474.
47. Brooks, SV and Faulkner, JA (1988). Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404: 71-82.
48. Hakim, CH, Li, D and Duan, D (2011). Monitoring murine skeletal muscle function for muscle gene therapy. Methods Mol Biol 709: 75-89.
49. Lueck, JD, Rossi, AE, Thornton, CA, Campbell, KP and Dirksen, RT (2010). Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle. J Gen Physiol 136: 597-613.